https://orcid.org/0000-0003-3746-1671
References
- Bloom BR, Michaud CM, La Montagne JR, et al. Priorities for global research and development of interventions. In: Jamison DT, Breman JG, Measham AR, et al., editors. Disease control priorities in developing countries. 2nd ed. Washington (DC): World Bank; 2006. p. 103–118.
- Chretien JP, Linthicum KJ. Chikungunya in Europe: what’s next? Lancet. 2007;370:1805–1806.
- Available from: https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts
- Grills A, Morrison S, Nelson B, et al. Projected Zika virus importation and subsequent ongoing transmission after travel to the 2016 Olympic and Paralympic games – country-specific assessment, July 2016. MMWR Morb Mortal Wkly Rep. 2016;65:711–7115.
- Quaglio G, Goerens C, Putoto G, et al. Ebola: lessons learned and future challenges for Europe. Lancet Infect Dis. 2016;16:259–263.
- Bobrowski T, Melo-Filho CC, Korn D, et al. Learning from history: do not flatten the curve of antiviral research! Drug Discov Today. 2020. in press. DOI:10.1016/j.drudis.2020.07.008.
- Padron-Regalado E. Vaccines for SARS-CoV-2: lessons from other coronavirus strains. Infect Dis Ther. 2020;9:255–274.